Expressions of 11beta-Hydroxysteroid Dehydrogenase Types 1 and 2 in Human Colorectal Cancer

被引：0

作者：

Wang Ji-rong ^{[1
]}

Xu Hong-xia ^{[2
]}

机构：

[1] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing 210011, Jiangsu, Peoples R China

[2] Jiangsu Tumor Hosp, Dept Internal Med, Nanjing 210011, Jiangsu, Peoples R China

来源：

JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE | 2014年 / 2卷 / 03期

关键词：

Colorectal cancer; Human; 11; beta-HSD1; gene; beta-HSD2;

D O I：

10.11910/2227-6394.2014.02.03.11

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Objective: To observe the expressions of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer. Methods: Neoplastic tissues and autologous non-neoplastic tissues were taken from 12 patients with colorectal cancer immediately after the operations. The mRNA expressions of 11betahydroxysteroid dehydrogenase type 1 (11 beta-HSD1) and 11beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) were detected by reverse transcription polymerase chain reaction (RT-PCR). The protein expressions of 11 beta-HSD1 and 11 beta-HSD2 were detected by Western-blot assay. Results: Both isoforms of 11 beta-HSD expressed in the colon adenocarcinoma, but their expressions were not identical in neoplastic and non-neoplastic tissues. There was a significant decrease of 11 beta-HSD2 mRNA abundance and protein abundance in neoplastic tissue. 11 beta-HSD1 protein and mRNA abundance were not significantly different from that in control tissue. Conclusions: Neoplastic transformation is associated with the decreases of 11 beta-HSD2 mRNA and protein.

引用

页码：403 / 407

页数：5

共 13 条

[1]

Albertin G, 2002, INT J MOL MED, V9, P495

[2] HEPATIC-ARTERY DEXAMETHASONE INFUSION INHIBITS COLORECTAL HEPATIC METASTASES - A REGIONAL ANTIANGIOGENIC THERAPY [J].

ARISAWA, Y ;

SUTANTOWARD, E ;

FORTUNATO, L ;

SIGURDSON, ER .

ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (02) :114-120

[3] Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells:: Involvement of nuclear factor-κB and Ets transcription factors [J].

Eberhardt, W ;

Schulze, M ;

Engels, C ;

Klasmeier, E ;

Pfeilschifter, J .

MOLECULAR ENDOCRINOLOGY, 2002, 16 (08) :1752-1766

[4] Expression and NNK reducing activities of carbonyl reductase and 11β-hydroxysteroid dehydrogenase type 1 in human lung [J].

Finckh, C ;

Atalla, A ;

Nagel, G ;

Stinner, B ;

Maser, E .

CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 130 (1-3) :761-773

[5] 11β-Hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck [J].

Gronau, S ;

Greger, DK ;

Jerg, M ;

Riechelmann, H .

CLINICAL OTOLARYNGOLOGY, 2002, 27 (06) :453-457

[6] Expression of the 11β-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell grow-th in PMC42 cells [J].

Koyama, K ;

Myles, K ;

Smith, R ;

Krozowski, Z .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 76 (1-5) :153-159

[7] Tumor progression: Defining the soil round the tumor seed [J].

McCawley, LJ ;

Matrisian, LM .

CURRENT BIOLOGY, 2001, 11 (01) :R25-R27

[8] Effect of cellular differentiation on 11β-hydroxysteroid dehydrogenase activity in the intestine [J].

Pácha, J ;

Lisá, W ;

Miksík, I .

STEROIDS, 2002, 67 (02) :119-126

[9] Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas:: a prereceptor determinant of pituitary cell proliferation [J].

Rabbitt, E ;

Ayuk, J ;

Boelaert, K ;

Sheppard, MC ;

Hewison, M ;

Stewart, PM ;

Gittoes, NJL .

ONCOGENE, 2003, 22 (11) :1663-1667

[10] 11β-hydroxysteroid dehydrogenases, cell proliferation and malignancy [J].

Rabbitt, EH ;

Gittoes, N ;

Stewart, PM ;

Hewison, A .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) :415-421

← 1 2 →